Literature DB >> 18585782

Is neurogenic hypertension related to vascular inflammation of the brainstem?

Julian F R Paton1, Hidefumi Waki.   

Abstract

Essential hypertension is idiopathic although it is accepted as a complex polygenic trait with underlying genetic components, which remain unknown. Our supposition is that hypertension involves activation of the sympathetic nervous system. One pivotal region controlling arterial pressure set point is nucleus tractus solitarii (NTS). We recently identified that pro-inflammatory molecules, such as junctional adhesion molecule-1 (JAM-1), were over expressed in endothelial cells of the microvasculature supplying the NTS in an animal model of human hypertension (the spontaneously hypertensive rat) compared to normotensive Wistar-Kyoto rats (WKY). Over expression of JAM-1 in NTS of WKY rats was pro-hypertensive and induced leukocyte adherence to the microvasculature. Since leukocyte adhesion causes cytokine release, we found expression of monocyte chemoattractant protein-1 (MCP-1) was higher in the NTS of SHR while inter-leukin-6 (IL-6) was lower compared to the WKY rat. Inflammation of the brainstem microvasculature may increase vascular resistance within the brainstem. High brainstem vascular resistance and its inflammation may release pathological paracrine signaling molecules affecting central neural cardiovascular activity conducive to neurogenic hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585782     DOI: 10.1016/j.neubiorev.2008.05.020

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  27 in total

Review 1.  The central nervous system and inflammation in hypertension.

Authors:  Paul J Marvar; Heinrich Lob; Antony Vinh; Faresa Zarreen; David G Harrison
Journal:  Curr Opin Pharmacol       Date:  2010-12-31       Impact factor: 5.547

Review 2.  Brain cytokines as neuromodulators in cardiovascular control.

Authors:  Peng Shi; Mohan K Raizada; Colin Sumners
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-06-29       Impact factor: 2.557

Review 3.  Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

4.  Effect of centrally acting angiotensin converting enzyme inhibitor on the exercise-induced increases in muscle sympathetic nerve activity.

Authors:  Gilbert Moralez; Noah P Jouett; Jun Tian; Matthew C Zimmerman; Paul Bhella; Peter B Raven
Journal:  J Physiol       Date:  2018-05-15       Impact factor: 5.182

5.  MicroRNA network changes in the brain stem underlie the development of hypertension.

Authors:  Danielle DeCicco; Haisun Zhu; Anthony Brureau; James S Schwaber; Rajanikanth Vadigepalli
Journal:  Physiol Genomics       Date:  2015-06-30       Impact factor: 3.107

Review 6.  Sex-specific immune modulation of primary hypertension.

Authors:  Kathryn Sandberg; Hong Ji; Meredith Hay
Journal:  Cell Immunol       Date:  2014-12-08       Impact factor: 4.868

Review 7.  Blood pressure regulation XI: overview and future research directions.

Authors:  Peter B Raven; Mark W Chapleau
Journal:  Eur J Appl Physiol       Date:  2014-01-28       Impact factor: 3.078

Review 8.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

9.  Shift to an involvement of phosphatidylinositol 3-kinase in angiotensin II actions on nucleus tractus solitarii neurons of the spontaneously hypertensive rat.

Authors:  Chengwen Sun; Jasenka Zubcevic; Jaimie W Polson; Jeffrey T Potts; Carlos Diez-Freire; Qi Zhang; Julian F R Paton; Mohan K Raizada
Journal:  Circ Res       Date:  2009-10-22       Impact factor: 17.367

10.  Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension.

Authors:  Heddwen L Brooks; Meredith Hay; Dennis P Pollow; Jennifer Uhrlaub; Melissa Romero-Aleshire; Kathryn Sandberg; Janko Nikolich-Zugich
Journal:  Hypertension       Date:  2014-06-02       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.